Want to join the conversation?
$BSX said that in 1Q16 it received FDA approval for the ACUITY X4 Quadripolar Left Ventricular Leads, which enables the company to offer a full X4 CRT system, consisting of the device and the leads to the US market. $BSX launched AXIOS Stent and Electrocautery Enhanced Delivery System to help physicians manage two serious pancreatic complications.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?